Working… Menu
Trial record 1 of 1 for:    NCT01516307
Previous Study | Return to List | Next Study

Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01516307
Recruitment Status : Completed
First Posted : January 24, 2012
Last Update Posted : September 16, 2020
Information provided by (Responsible Party):
OBI Pharma, Inc

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2016
Actual Study Completion Date : August 2019
Certification/Extension First Submitted : March 2, 2017